VIM, vimentin, 7431

N. diseases: 644; N. variants: 6
Disease: Non-squamous non-small cell lung cancer ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C4324656
Disease: Non-squamous non-small cell lung cancer
Non-squamous non-small cell lung cancer 		0.010 Biomarker disease BEFREE The aim of the present study was to assess the expression of epithelial-mesenchymal transition biomarkers (E-cadherin and vimentin) and their potential significance as prognostic markers in patients with stage IIIB/IV non-squamous non-small cell lung cancer (NSCLC) enrolled in the INNOVATIONS trial, receiving treatment with either erlotinib/bevacizumab (EB) or cisplatin/gemcitabine/bevacizumab (PGB). 31186697 2019